MedPath
HSA Approval

BEAFEMIC CAPSULES 250 mg

SIN05376P

BEAFEMIC CAPSULES 250 mg

BEAFEMIC CAPSULES 250 mg

January 29, 1991

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

M01AG01

mefenamic acid

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

MEFENAMIC ACID

250 mg

Mefenamic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEAFEMIC CAPSULES 250 mg - HSA Approval | MedPath